99 related articles for article (PubMed ID: 9642974)
1. Airway lesions and superoxide dismutase (SOD) distribution in bronchopulmonary dysplasia (BPD).
Ohbayashi C; Kanomata N; Hanioka K; Itoh H
Kobe J Med Sci; 1997 Oct; 43(5):191-211. PubMed ID: 9642974
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary neuroendocrine cells in pediatric lung disease: alterations in airway structure in infants with bronchopulmonary dysplasia.
Johnson DE; Anderson WR; Burke BA
Anat Rec; 1993 May; 236(1):115-9, 172-3; discussion 120-1. PubMed ID: 8506996
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxidation and expression of copper-zinc and manganese superoxide dismutase in lungs of premature infants with hyaline membrane disease and bronchopulmonary dysplasia.
Strange RC; Cotton W; Fryer AA; Jones P; Bell J; Hume R
J Lab Clin Med; 1990 Nov; 116(5):666-73. PubMed ID: 2230537
[TBL] [Abstract][Full Text] [Related]
4. Pathological and histometrical studies on alveolar ducts and respiratory bronchioli.
Wakafuji S
Kobe J Med Sci; 1985 Oct; 31(5):203-20. PubMed ID: 4094381
[No Abstract] [Full Text] [Related]
5. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia.
Johnson DE; Lock JE; Elde RP; Thompson TR
Pediatr Res; 1982 Jun; 16(6):446-54. PubMed ID: 7099761
[TBL] [Abstract][Full Text] [Related]
6. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia.
Cherukupalli K; Larson JE; Rotschild A; Thurlbeck WM
Pediatr Pulmonol; 1996 Oct; 22(4):215-29. PubMed ID: 8905882
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary sequelae of reparative stages of bronchopulmonary dysplasia.
Anderson WR; Engel RR
Arch Pathol Lab Med; 1983 Nov; 107(11):603-8. PubMed ID: 6688719
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of copper-zinc and manganese superoxide dismutases in the lungs of human fetuses and newborn infants: developmental profile and alterations in hyaline membrane disease and bronchopulmonary dysplasia.
Dobashi K; Asayama K; Hayashibe H; Munim A; Kawaoi A; Morikawa M; Nakazawa S
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):177-84. PubMed ID: 8236811
[TBL] [Abstract][Full Text] [Related]
9. The progression of morphologic changes in bronchopulmonary dysplasia.
Erickson AM; de la Monte SM; Moore GW; Hutchins GM
Am J Pathol; 1987 Jun; 127(3):474-84. PubMed ID: 3647732
[TBL] [Abstract][Full Text] [Related]
10. [Toxicity of oxygen and (Cu) superoxide dismutase and (Mn) superoxide dismutase in newborn infants with respiratory distress. Preliminary results].
Lindenbaum A; Magny JF; Abella A; Chalas J; Baret A; Dehan M
Pathol Biol (Paris); 1987 Feb; 35(2):173-6. PubMed ID: 3550627
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease.
Taghizadeh A; Reynolds EO
Am J Pathol; 1976 Feb; 82(2):241-64. PubMed ID: 175660
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary dysplasia in infancy. Pathogenesis, pneumologic course studies and therapy possibilities].
Becker B; Reinhardt D; Risselmann K; Morgenroth K; Kemperdick H; Lemburg P
Monatsschr Kinderheilkd; 1984 Jul; 132(7):525-33. PubMed ID: 6472297
[TBL] [Abstract][Full Text] [Related]
13. Bombesin-, calcitonin-, and serotonin-immunoreactive pulmonary neuroendocrine cells in acute and chronic neonatal lung disease.
Johnson DE; Kulik TJ; Lock JE; Elde RP; Thompson TR
Pediatr Pulmonol; 1985; 1(3 Suppl):S13-20. PubMed ID: 4069801
[TBL] [Abstract][Full Text] [Related]
14. Airway dimensions in bronchopulmonary dysplasia: implications for airflow obstruction.
Tiddens HA; Hofhuis W; Casotti V; Hop WC; Hulsmann AR; de Jongste JC
Pediatr Pulmonol; 2008 Dec; 43(12):1206-13. PubMed ID: 18991341
[TBL] [Abstract][Full Text] [Related]
15. Family history of asthma in infants with bronchopulmonary dysplasia.
Nickerson BG; Taussig LM
Pediatrics; 1980 Jun; 65(6):1140-4. PubMed ID: 7375238
[TBL] [Abstract][Full Text] [Related]
16. Morphometric analysis of the lung in bronchopulmonary dysplasia.
Margraf LR; Tomashefski JF; Bruce MC; Dahms BB
Am Rev Respir Dis; 1991 Feb; 143(2):391-400. PubMed ID: 1990959
[TBL] [Abstract][Full Text] [Related]
17. Pathology of bronchopulmonary dysplasia.
Coalson JJ
Semin Perinatol; 2006 Aug; 30(4):179-84. PubMed ID: 16860157
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathologic study.
Van Lierde S; Cornelis A; Devlieger H; Moerman P; Lauweryns J; Eggermont E
Biol Neonate; 1991; 60(3-4):152-62. PubMed ID: 1797116
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Molybdenum Trioxide (CAS No. 1313-27-5) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Apr; 462():1-269. PubMed ID: 12587014
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological study of diffuse panbronchiolitis--with special reference to relationship between the clinical duration and respiratory bronchiolar lesions].
Kamoshida T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):169-79. PubMed ID: 8515596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
